The Esmo Magnitude of Clinical Benefit Scale for Novel Cancer Medicines — Correspondence with Prioritization Decisions In Updating the Israeli National List of Health Services
Abstract
Authors
A Hammerman S Greenberg-Dotan I Feldhamer Y Birnbaum NI Cherny